No Data
No Data
PROCEPT BioRobotics | 10-Q: Q1 2025 Earnings Report
Jefferies Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Intuitive Surgical (ISRG) and Bio-Rad Laboratories (BIO)
PROCEPT BioRobotics to Attend Four Upcoming Investor Conferences in May & June
Earnings Release: Here's Why Analysts Cut Their PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target To US$77.00
Buy Rating for PROCEPT BioRobotics: Promising Growth in Cancer Treatment Market and BPH Advancements